Jean M. Franchi Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

Jean M. Franchi is Chief Financial Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 69,530 shares of GMTX, which is worth approximately $1.69 Million. The most recent transaction as insider was on Feb 18, 2025, when has been sold 3,136 shares (Common Stock) at a price of $54.58 per share, resulting in proceeds of $171,162. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.5K
89.63% 3M change
89.63% 12M change
Total Value Held $1.69 Million

Jean M. Franchi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2025
SELL
Open market or private sale
$171,162 $54.58 p/Share
3,136 Reduced 4.32%
69,530 Common Stock
Feb 10 2025
BUY
Grant, award, or other acquisition
-
36,000 Added 33.13%
72,666 Common Stock
Feb 07 2024
BUY
Grant, award, or other acquisition
-
36,666 Added 50.0%
36,666 Common Stock

Also insider at

REPL
Replimune Group, Inc. Healthcare
Chief Financial Officer
BDSX
BIODESIX INC Healthcare
JMF

Jean M. Franchi

Chief Financial Officer
Woburn, MA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX